FDA takes first step in possible reversal of ban on some peptides The Washington Post The FDA is reviewing 12 peptides for removal from its restricted listincluding BPC 157, TB 500, Semax, and GHK Cu. If it goes through, it's the biggest peptide policy shift in years. More access. Easier Regulatory Alert: FDA's April 2026 Update on BPC 157 and GHK Cu Holt Law FDA to weigh easing limits on unproven peptides favored by RFK Jr. and MAHA supporters PBS News A Note on Peptides by Shantanu Out of Singapore BPC 157: Miracle Healing Peptide or Hidden Danger?